ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
After delayed IPO, Mereo gets US listing via OncoMed merger
December 10, 2018UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline and gives it a potential licensing deal with Celgene...... -
Mereo BioPharma and OncoMed propose merger
December 10, 2018The transaction will create a combined business with a diversified combined portfolio of seven assets, which will result in an increased number of potential near-term catalysts with a core focus remaining -
Celgene walks away from Oncomed’s navicixizumab
September 27, 2018Celgene has decided not to exercise its option to license OncoMed's bispecific antibody navicixizumab. -
OncoMed Cuts Workforce in Half
April 26, 2017Will focus on advancing three clinical-stage programs to milestones
Pharma Sources Insight January 2025
